| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | LQDA Liquidia Corp | Adair Jason | Chief Business Officer | Sell | 455 | $9.50 | $4,322.36 | -0.4% | +23.4% | +221.1% | |
| Sep 3, 2024 | CWBHF Charlotte's Web Holdings, Inc. | Kunkel Raymond J. | Chief Operating Officer | Buy | 135,746 | $0.15 | $20,289.47 | +41.0% | - | - | |
| Sep 3, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Moat Ross | Chief Commercial Officer | Sell | 68,506 | $26.12 | $1,789,189.80 | -60.6% | -16.0% | +36.4% | |
| Aug 30, 2024 | EOLS Evolus, Inc. | Yamagishi-Dressler Tomoko74 | Chief Marketing Officer | Sell | 5,631 | $15.85 | $89,251.35 | -6.4% | -13.8% | -52.0% | |
| Aug 30, 2024 | JNJ Johnson & Johnson | Decker Robert J56 | VP Corporate Controller | Sell | 5,635 | $165.06 | $930,113.10 | -22.9% | -6.5% | +6.8% | |
| Aug 30, 2024 | LQDA Liquidia Corp | Caligan Partners LP61 | Director, 10% Owner, See Remarks | Buy | 150,000 | $9.51 | $1,426,500.00 | +2.2% | +21.5% | +191.1% | |
| Aug 30, 2024 | TLPH Talphera, Inc. | Angotti Vincent J.56 | Chief Executive Officer | Buy | 7,260 | $1.05 | $7,598.32 | +3.8% | -32.0% | -48.0% | |
| Aug 30, 2024 | LQDA Liquidia Corp | Caligan Partners LP61 | Director, 10% Owner, See Remarks | Sell | 150,000 | $9.51 | $1,426,500.00 | -2.1% | +21.5% | +191.1% | |
| Aug 30, 2024 | VTRS Viatris Inc | Malik Rajiv61 | Director | Sell | 100,000 | $11.95 | $1,195,075.00 | -36.9% | +8.4% | -12.7% | |
| Aug 28, 2024 | MIRA Mira Pharmaceuticals, Inc. | McNulty Brian Patrick88 | 10% Owner | Sell | 200,000 | $1.96 | $392,000.00 | -7.3% | -25.6% | -18.6% | |
| Aug 28, 2024 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 5,000 | $0.09 | $450.00 | +0.1% | - | - | |
| Aug 28, 2024 | CWBHF Charlotte's Web Holdings, Inc. | Kunkel Raymond J. | Chief Operating Officer | Buy | 12,000 | $0.14 | $1,710.00 | +6.4% | - | - | |
| Aug 27, 2024 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 24,552 | $968.46 | $23,777,667.73 | - | -20.9% | -23.1% | |
| Aug 27, 2024 | KNSA Kiniksa Pharmaceuticals International, Plc | Tessari Eben | Chief Operating Officer | Sell | 17,500 | $26.91 | $470,925.00 | -12.7% | -19.4% | +24.5% | |
| Aug 27, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 60,000 | $0.22 | $13,200.00 | - | - | - | |
| Aug 27, 2024 | ETST Earth Science Tech, Inc. | Cazeau Jeff P. H. | Independent Director | Buy | 45,409 | $0.22 | $9,989.98 | +84.7% | - | - | |
| Aug 27, 2024 | HIMS Hims & Hers Health, Inc. | Pendarvis Christiane | Director | Sell | 7,000 | $15.15 | $106,064.00 | -22.6% | +111.3% | +196.6% | |
| Aug 26, 2024 | PRGO Perrigo Co Plc | Janish Ronald Craig61 | EVP, Gbl Ops &Sc &CTO | Sell | 13,000 | $29.40 | $382,245.50 | -38.7% | -2.8% | -18.8% | |
| Aug 26, 2024 | AMPH Amphastar Pharmaceuticals, Inc. | Zhou Rong59 | Senior EVP, Production Center | Sell | 4,000 | $48.35 | $193,400.00 | -3.3% | -7.3% | -37.0% | |
| Aug 26, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 269 | $348.41 | $93,722.92 | -24.5% | +6.3% | -10.8% | |
| Aug 26, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 104,732 | $0.20 | $21,149.08 | - | - | - | |
| Aug 26, 2024 | UTHR United Therapeutics Corp | Edgemond James | CFO And Treasurer | Sell | 7,799 | $347.60 | $2,710,932.40 | -46.1% | +6.3% | -10.8% | |
| Aug 26, 2024 | LLY Eli Lilly & Co | Zakrowski Donald A | SVP, Finance, &CAO | Sell | 750 | $950.00 | $712,500.00 | -10.5% | -20.6% | -22.6% | |
| Aug 23, 2024 | ETST Earth Science Tech, Inc. | Tabraue Mario Guillermo | COO | Buy | 6,000 | $0.18 | $1,050.00 | - | - | - | |
| Aug 23, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $347.47 | $2,501,765.36 | -34.6% | +5.6% | -10.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.